BioCryst Pharmaceuticals BCRX Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 97.8%-0.1pp | 97.8%+0.4pp | 97.4%+0.4pp | 97%+0.1pp | 96.9%-0.4pp | |
| Operating margin | -43.1%-82.1pp | 39%+26.3pp | 12.7%+3.0pp | 9.7%+3.1pp | 6.6%+7.2pp | |
| Net margin | -51.7%-81.9pp | 30.2%+31.6pp | -1.5%+4.9pp | -6.4%+4.2pp | -10.6%+9.1pp | |
| Efficiency | ||||||
| Asset turnover | 1.9×+0.1× | 1.7×+0.5× | 1.3×+0.1× | 1.2×+0.1× | 1.1×+0.2× | |
| Liquidity | ||||||
| Current ratio | 1.9×-0.2× | 2.1×+0.2× | 1.9×-0.4× | 2.2×-0.7× | 2.9×+0.3× | |
| Per Share | ||||||
| Book value per share | -$2.29-319% | -$0.55+69.1% | -$1.76+8.0% | -$1.92+8.7% | -$2.10+8.8% | |
| Valuation | ||||||
| Market capitalization | $2.39B+45.3% | $1.64B+3.2% | $1.59B-23.3% | $2.08B+32.6% | $1.57B+0.6% | |
| Price / sales | 2.7×+0.8× | 1.9×-0.8× | 2.7×-1.1× | 3.7×+0.6× | 3.1×-0.3× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are BioCryst Pharmaceuticals's profit margins?
- BioCryst Pharmaceuticals (BCRX) runs a 97.8% gross margin and a -43.1% operating margin, with a -51.7% net margin.
- Where do BioCryst Pharmaceuticals's ratios come from?
- Every ratio is computed from BioCryst Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
